Tenet Healthcare Corporation (THC)
- Previous Close
120.28 - Open
121.73 - Bid 48.95 x 1000
- Ask --
- Day's Range
119.37 - 122.39 - 52 Week Range
51.04 - 122.39 - Volume
1,222,509 - Avg. Volume
1,285,426 - Market Cap (intraday)
11.952B - Beta (5Y Monthly) 2.14
- PE Ratio (TTM)
4.75 - EPS (TTM)
25.77 - Earnings Date Jul 29, 2024 - Aug 2, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date Mar 13, 2000
- 1y Target Est
--
Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies. The company also provides intensive and critical care, and/or coronary care units; cardiovascular, digestive disease, neurosciences, musculoskeletal, and obstetrics services; outpatient services, including physical therapy; tertiary care services, such as cardiothoracic surgery, complex spinal surgery, neonatal intensive care, and neurosurgery services; quaternary care services in heart and kidney transplants; and limb salvaging vascular procedure, acute level 1 trauma, intravascular stroke care, minimally invasive cardiac valve replacement, imaging, surgical robotic, and telemedicine access services. In addition, it offers a range of procedures and services, such as orthopedics, total joint replacement, and spinal and other musculoskeletal procedures; gastroenterology; pain management; otolaryngology; ophthalmology; and urology. It operates hospitals, ambulatory surgery centers, imaging centers, surgical hospitals, off-campus emergency departments, and micro-hospitals. Tenet Healthcare Corporation was founded in 1967 and is headquartered in Dallas, Texas.
www.tenethealth.com78,810
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: THC
Performance Overview: THC
Trailing total returns as of 5/6/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: THC
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: THC
Valuation Measures
Market Cap
11.95B
Enterprise Value
22.35B
Trailing P/E
4.75
Forward P/E
15.60
PEG Ratio (5yr expected)
1.59
Price/Sales (ttm)
0.61
Price/Book (mrq)
3.46
Enterprise Value/Revenue
1.07
Enterprise Value/EBITDA
3.68
Financial Highlights
Profitability and Income Statement
Profit Margin
12.54%
Return on Assets (ttm)
6.61%
Return on Equity (ttm)
53.69%
Revenue (ttm)
20.89B
Net Income Avi to Common (ttm)
2.62B
Diluted EPS (ttm)
25.77
Balance Sheet and Cash Flow
Total Cash (mrq)
2.48B
Total Debt/Equity (mrq)
167.89%
Levered Free Cash Flow (ttm)
2.49B
Research Analysis: THC
Company Insights: THC
Fair Value
Dividend Score
Hiring Score
Insider Sentiment Score
Research Reports: THC
THC: Raising target price to $118.00
TENET HEALTHCARE CORP has an Investment Rating of HOLD; a target price of $118.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Low; a Financial Strength Subrating of Medium; a Growth Subrating of High; and a Value Subrating of Low.
RatingPrice TargetAnalyst Report: Tenet Healthcare Corporation
Tenet Healthcare is a Dallas-based healthcare services organization. It operates a collection of hospitals (about 60 as of December 2023) and over 450 ambulatory surgery centers and other outpatient facilities across the U.S., primarily in the South. Through its Conifer segment, Tenet also provides revenue cycle management solutions.
RatingPrice TargetTHC: What does Argus have to say about THC?
TENET HEALTHCARE CORP has an Investment Rating of HOLD; a target price of $103.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Low; a Financial Strength Subrating of Medium; a Growth Subrating of High; and a Value Subrating of Low.
RatingPrice TargetTHC: Lowering target price to $103.00
TENET HEALTHCARE CORP has an Investment Rating of HOLD; a target price of $103.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Low; a Financial Strength Subrating of Medium; a Growth Subrating of High; and a Value Subrating of Low.
RatingPrice Target